1003-3734
2016 Issue 9
..............page:959-960
Nivolumab: a new PD-1 inhibitor
WANG Li;ZHANG Zhi-ye;The First People’s Hospital of Lanzhou;
WANG Li;ZHANG Zhi-ye;The First People’s Hospital of Lanzhou;
..............page:961-963
Data mining and association analysis of total related substance and adverse reaction rate of antibiotics
CONG Luo-luo;WU Bin;GUO Hong-zhu;SHAO Ming-li;School of International Pharmaceutical Business;China Pharmaceutical University;Beijing institute For Drug Control;
CONG Luo-luo;WU Bin;GUO Hong-zhu;SHAO Ming-li;School of International Pharmaceutical Business;China Pharmaceutical University;Beijing institute For Drug Control;
..............page:964-967
Inspiration from cases of atorvastatin and lenalidomide:Concealment of technical essentials in drug patents
HAN Lei;TAO Yuan;State Intellectual Property Office Patent Office;Chinese Medical Association;
HAN Lei;TAO Yuan;State Intellectual Property Office Patent Office;Chinese Medical Association;
..............page:968-972
Thinking on the translation of new drug from medical institution pharmaceutical of TCM
LI Can;DING Jian-hua;LIU Chun;FU Jian-hua;ZHAN Jia-yi;ZHANG Ti-deng;WANG Hai-nan;Institute of Clinical Pharmacy;Beijing Municipal Health Bureau;Center for Food and Drug Inspection of CFDA;Department of Cosmetic and Drug Registration;China Food and Drug Administration;Xiyuan Hospital;China Academy of Chinese Medical Sciences;
LI Can;DING Jian-hua;LIU Chun;FU Jian-hua;ZHAN Jia-yi;ZHANG Ti-deng;WANG Hai-nan;Institute of Clinical Pharmacy;Beijing Municipal Health Bureau;Center for Food and Drug Inspection of CFDA;Department of Cosmetic and Drug Registration;China Food and Drug Administration;Xiyuan Hospital;China Academy of Chinese Medical Sciences;
..............page:973-975
Researching new version of national essential medicine list:ensuring medication for children
WANG Chen-yang;TIAN Kan;LIU Yi-sheng;DONG Qing;Nanjing University of Chinese Medicine;Jiangsu Food and Drug Administration;
WANG Chen-yang;TIAN Kan;LIU Yi-sheng;DONG Qing;Nanjing University of Chinese Medicine;Jiangsu Food and Drug Administration;
..............page:976-980
Histopathological examination process in GLP evaluation of drug safety
SUN Chang-hua;ZHU Qing-fen;Drug Evaluation Center of Shandong Foot Institute for Food and Drug Control;
SUN Chang-hua;ZHU Qing-fen;Drug Evaluation Center of Shandong Foot Institute for Food and Drug Control;
..............page:981-984
Latest progress of compendial procedure validation
WANG Ping-ping;ZHANG Yuan;TAN De-jiang;YANG Hua-xin;China Pharmaceutical University;National institutes for Food and Drug Control;
WANG Ping-ping;ZHANG Yuan;TAN De-jiang;YANG Hua-xin;China Pharmaceutical University;National institutes for Food and Drug Control;
..............page:985-990
Advances in cardiotoxicity study of exogenous compounds in vitro
ZHAO Qi;WANG Xi-jie;MA Jing;China State Institutes of Pharmaceutical Industry National Shanghai Center for New Drug Safety Evaluation and Research;
ZHAO Qi;WANG Xi-jie;MA Jing;China State Institutes of Pharmaceutical Industry National Shanghai Center for New Drug Safety Evaluation and Research;
..............page:991-995
Trend prediction for moisture change in finished products of live attenuated Japanese encephalitis vaccine(JEV) based on the real-time stability data
ZHU Xiao-nong;LUO Jing;LIU Yi-nan;NAN Fang;LIU Ju;Chengdu Institute of Biological Products Co.;Ltd.;
ZHU Xiao-nong;LUO Jing;LIU Yi-nan;NAN Fang;LIU Ju;Chengdu Institute of Biological Products Co.;Ltd.;
..............page:996-1000
Advance in synthesis of antitumor compound Jaspine B
ZHANG En;WANG Shang;GAO Jie;XU Shuai-min;LIU Hong-min;School of Pharmaceutical Science;Zhengzhou University;Collaborative Innovation Center of New Drug Research and Safety Evaluation;
ZHANG En;WANG Shang;GAO Jie;XU Shuai-min;LIU Hong-min;School of Pharmaceutical Science;Zhengzhou University;Collaborative Innovation Center of New Drug Research and Safety Evaluation;
..............page:1001-1012
Evaluation of drug delivery to central nervous system in vivo
HUANG Yuan;TAO Yan;LI Rui;XU Qun-wei;Nanjing Madical University;
HUANG Yuan;TAO Yan;LI Rui;XU Qun-wei;Nanjing Madical University;
..............page:1013-1017
Research advance of resistance mechanism of EML4-ALK related targeted drug and reversal resistance in non-small cell lung cancer
LIU Xiao;JIA Yan-hua;ZHANG Ke;LIU Gui-yang;Department of Pharmacy;the First Affiliated Hospital of PLA General Hospital;Hebei North University;
LIU Xiao;JIA Yan-hua;ZHANG Ke;LIU Gui-yang;Department of Pharmacy;the First Affiliated Hospital of PLA General Hospital;Hebei North University;
..............page:1018-1023
Progress in studies of tedizolid synthesis and structure-activity relationship
CAO Yu-ting;LIU Qian-feng;SHEN Ning;FENG Guang-jun;FENG Jian-jun;Faculty of Science in Xi’an University of Architecture and Technology;Xi’an Ruilian Modern Electronic Chemical Co.;Ltd.;
CAO Yu-ting;LIU Qian-feng;SHEN Ning;FENG Guang-jun;FENG Jian-jun;Faculty of Science in Xi’an University of Architecture and Technology;Xi’an Ruilian Modern Electronic Chemical Co.;Ltd.;
..............page:1024-1028
Clinical recommendation on paliperidone extended-release tablets(second edition)
SI Tian-mei;HUANG Ji-zhong;LI Xiao-bai;JIANG Kai-da;YANG Fu-de;HAO Wei;WANG Gao-hua;MEI Qi-yi;LIU Tie-bang;LI Tao;WANG Xue-yi;XU Xiu-feng;TAN Qing-rong;SHI Jian-fei;JIAO Zhi-an;LI Yi;YU Xin;Peking University the Sixth Hospital;Shanghai Mental Health Center;The First Hospital of China Medical University;Beijing Hui Long Guan Hospital;The Second Xiangya Hospital of Central South University;Renmin Hospital of Wuhan University;Suzhou Guangji Hospital;Shenzhen Kangning Hospital;West China Hospital of Sichuan;The First Hospital of Hebei Medical University;First Affiliated Hospital of Kunming Medical College;The First Hospital of The Fourth Military Medical University Xijing Hospital;Mental Health Center School of Medicine Zhejiang University;Hangzhou Seventh People’s Hospital;Shandong Provincial Hospital;Wuhan Mental Health Center;
SI Tian-mei;HUANG Ji-zhong;LI Xiao-bai;JIANG Kai-da;YANG Fu-de;HAO Wei;WANG Gao-hua;MEI Qi-yi;LIU Tie-bang;LI Tao;WANG Xue-yi;XU Xiu-feng;TAN Qing-rong;SHI Jian-fei;JIAO Zhi-an;LI Yi;YU Xin;Peking University the Sixth Hospital;Shanghai Mental Health Center;The First Hospital of China Medical University;Beijing Hui Long Guan Hospital;The Second Xiangya Hospital of Central South University;Renmin Hospital of Wuhan University;Suzhou Guangji Hospital;Shenzhen Kangning Hospital;West China Hospital of Sichuan;The First Hospital of Hebei Medical University;First Affiliated Hospital of Kunming Medical College;The First Hospital of The Fourth Military Medical University Xijing Hospital;Mental Health Center School of Medicine Zhejiang University;Hangzhou Seventh People’s Hospital;Shandong Provincial Hospital;Wuhan Mental Health Center;
..............page:1029-1035
Efficacy of rifaximin tablet combined with Bifid-triple viable capsule in 84 middle-aged and elderly patients of acute infectious diarrhea
WANG Wei;CUI Li-hong;Medical School of Chinese PLA;Navy General Hospital;
WANG Wei;CUI Li-hong;Medical School of Chinese PLA;Navy General Hospital;
..............page:1036-1039
Absorption and transportation characteristics of FGFC1 in Caco-2 cell monolayer
WANG Ge;YAN Ting;FU Shi-qing;WU Wen-hui;ZHANG Chao-yan;BAO Bin;College of Food Science and Technology of Shanghai Ocean University;Shanghai Aquatic Products Processing and Storage Engineering Technology Research Center;Institute of Marine Science of Shanghai Ocean University;
WANG Ge;YAN Ting;FU Shi-qing;WU Wen-hui;ZHANG Chao-yan;BAO Bin;College of Food Science and Technology of Shanghai Ocean University;Shanghai Aquatic Products Processing and Storage Engineering Technology Research Center;Institute of Marine Science of Shanghai Ocean University;
..............page:1040-1045
Evaluation on the influence of Yiqifumai injection on the activities of cytochrome P450 enzymes in rats by cocktail probe approach
LI Ting-yang;LI Xiao;ZHOU Hong-jie;CHU Yang;ZHOU Da-zheng;WANG Xiang-yang;LI Wei;YANG Jin;JU Ai-chun;LIU Chang-xiao;Center of Drug Metabolism and Pharmacokinetics;China Pharmaceutical University;Tasly Academy;Tasly Holding Group Co.;Ltd.;State Key Laboratory of Core Technology in Innovative Chinese Medicine;Tasly Pharmaceutical Group Co.;Ltd.;Tianjin Tasly Pride Pharmaceutical Co.;Ltd.;Tianjin Key Laboratory of Advanced Technology Enterprise of TCM Injections;National Resource Center for Chinese Materia Medica;China Academy of Chinese Medical Sciences;The State Key Laboratory of Drug Delivery Technology and Pharmacokinetics;Tianjin Institute of Pharmaceutical Research;
LI Ting-yang;LI Xiao;ZHOU Hong-jie;CHU Yang;ZHOU Da-zheng;WANG Xiang-yang;LI Wei;YANG Jin;JU Ai-chun;LIU Chang-xiao;Center of Drug Metabolism and Pharmacokinetics;China Pharmaceutical University;Tasly Academy;Tasly Holding Group Co.;Ltd.;State Key Laboratory of Core Technology in Innovative Chinese Medicine;Tasly Pharmaceutical Group Co.;Ltd.;Tianjin Tasly Pride Pharmaceutical Co.;Ltd.;Tianjin Key Laboratory of Advanced Technology Enterprise of TCM Injections;National Resource Center for Chinese Materia Medica;China Academy of Chinese Medical Sciences;The State Key Laboratory of Drug Delivery Technology and Pharmacokinetics;Tianjin Institute of Pharmaceutical Research;
..............page:1046-1051
Study on the pharmacokinetics of neoline at different doses in rats
GONG Xiao-hong;ZHAO Meng-jie;YUAN An;LI Yan;YAN Pei-ao;PENG Cheng;LI Yun-xia;Pharmacy College;Chengdu University of Traditional Chinese Medicine;State Key Laboratory Breeding Base of Systematic Research;Development and Utilization of Chinese Medicine Resources Co-founded by Sichuan Province and MOST;The Ministry of Education Key Laboratory of Standardization of Chinese Herbal;Sichuan Medicine;
GONG Xiao-hong;ZHAO Meng-jie;YUAN An;LI Yan;YAN Pei-ao;PENG Cheng;LI Yun-xia;Pharmacy College;Chengdu University of Traditional Chinese Medicine;State Key Laboratory Breeding Base of Systematic Research;Development and Utilization of Chinese Medicine Resources Co-founded by Sichuan Province and MOST;The Ministry of Education Key Laboratory of Standardization of Chinese Herbal;Sichuan Medicine;
..............page:1052-1056
The preparation of febuxostat by Suzuki reaction
CAO Qian-ming;MA Xiao-li;XIONG Jie-ming;GUO Pan;GU Cui-ying;YUE Hui;QIN Fei-fei;PENG Xiao-ming;LIU Bo;JU Rui-jun;CHAO Jian-ping;School of Chemical Engineering;Being Institute of Petrochemical Technology;
CAO Qian-ming;MA Xiao-li;XIONG Jie-ming;GUO Pan;GU Cui-ying;YUE Hui;QIN Fei-fei;PENG Xiao-ming;LIU Bo;JU Rui-jun;CHAO Jian-ping;School of Chemical Engineering;Being Institute of Petrochemical Technology;
..............page:1057-1060
Development of novel adriamycin-loaded nanoparticles and its inhibitory effect on osteosarcoma cells
SUN Kuo;CHEN Tong-yi;WANG Jing;ZHANG Jian;Department of Orthopedics;the Second Affiliated Hospital to Nanchang University;Department of Orthopedics;Zhongshan Hospital;Fudan University;School of Materials Science and Engineering;East China University of Science and Technology;
SUN Kuo;CHEN Tong-yi;WANG Jing;ZHANG Jian;Department of Orthopedics;the Second Affiliated Hospital to Nanchang University;Department of Orthopedics;Zhongshan Hospital;Fudan University;School of Materials Science and Engineering;East China University of Science and Technology;
..............page:1061-1068
Formula optimization of echinacoside-loaded PLGA nanoparticles by Box-Behnken design and response surface method
SU Shan-shan;CHEN Wen;FANG He;LI Jia;ZHANG Ya;HAN Bo;Department of Pharmacy;College of Pharmacy;Shihezi University;
SU Shan-shan;CHEN Wen;FANG He;LI Jia;ZHANG Ya;HAN Bo;Department of Pharmacy;College of Pharmacy;Shihezi University;
..............page:1069-1074
Preparation and pharmaceutical study of microemulsion gel system for transdermal delivery of celecoxib
HUANG Kai-yu;WU Chun-yan;CHEN Guo-guang;REN Li-li;School of Pharmaceutical Sciences;Nanjing Tech University;Jiangsu Nowa Pharmaceutical Co.;Ltd.;
HUANG Kai-yu;WU Chun-yan;CHEN Guo-guang;REN Li-li;School of Pharmaceutical Sciences;Nanjing Tech University;Jiangsu Nowa Pharmaceutical Co.;Ltd.;
..............page:1075-1080